A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])
Keyword(s):
Phase Ii
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. e15118-e15118
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 4547-4547
◽